{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:24:01Z","timestamp":1790029441636,"version":"4.0.1"},"reference-count":186,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jiph.2025.102940","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:29:34Z","timestamp":1756402174000},"page":"102940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mpox infection: A state-of-the-art overview of epidemiological, molecular, and clinical aspects following the 2024 public health emergency"],"prefix":"10.1016","volume":"18","author":[{"given":"Shayan","family":"Zamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Noroozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Hasanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8321-4329","authenticated-orcid":false,"given":"Erfan","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Trinidad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Firooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2025.102940_bib1","unstructured":"W. H. Organization. \"WHO recommends new name for monkeypox disease.\" \u3008https:\/\/www.who.int\/news\/item\/28-11-2022-who-recommends-new-name-for-monkeypox-disease\u3009 (accessed."},{"issue":"12","key":"10.1016\/j.jiph.2025.102940_bib2","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.cmi.2023.07.011","article-title":"A contemporary review of clade-specific virological differences in monkeypox viruses","volume":"29","author":"Okwor","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"Pt 10","key":"10.1016\/j.jiph.2025.102940_bib3","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","article-title":"A tale of two clades: monkeypox viruses","volume":"86","author":"Likos","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jiph.2025.102940_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fpubh.2018.00241","article-title":"Emergence of monkeypox as the most important orthopoxvirus infection in humans","volume":"6","author":"Sklenovsk\u00e1","year":"2018","journal-title":"Front Public Health"},{"issue":"9","key":"10.1016\/j.jiph.2025.102940_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005857","article-title":"Enhancing case definitions for surveillance of human monkeypox in the democratic Republic of Congo","volume":"11","author":"Osadebe","year":"2017","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib6","unstructured":"W. H. Organization. \"Mpox Global Dashboard.\" \u3008https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib7","unstructured":"W. H. Organization. \"Disease Outbreak news.\" \u3008https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2024-DON528\u3009 (accessed."},{"issue":"6","key":"10.1016\/j.jiph.2025.102940_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.2136","article-title":"Prediction of potential public health risk of the recent multicountry monkeypox outbreak: an update after the end declaration of global public health emergency","volume":"7","author":"Haque","year":"2024","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.jiph.2025.102940_bib9","unstructured":"W. H. Organization. \"WHO Director-General declares mpox outbreak a public health emergency of international concern.\" \u3008https:\/\/www.who.int\/news\/item\/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib10","series-title":"Geneva, December 1979","article-title":"The global eradication of smallpox: final report of the global commission for the certification of smallpox eradication","author":"W. H. O. (WHO)","year":"1980"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1473-3099(03)00856-9","article-title":"Human monkeypox: an emerging zoonosis","volume":"4","author":"Di Giulio","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2025.102940_bib12","first-page":"593","article-title":"A human infection caused by monkeypox virus in basankusu territory, democratic republic of the Congo","volume":"46","author":"Ladnyj","year":"1972","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jiph.2025.102940_bib13","first-page":"156","volume":"46","author":"Magnus","year":"1959"},{"key":"10.1016\/j.jiph.2025.102940_bib14","unstructured":"J.G. Breman, Kalisa-Ruti, M.V. Steniowski, E. Zanotto, A.I. Gromyko, and I. Arita, \"Human monkeypox, 1970-79,\" vol. 58, ed: World Health Organization, 1980, p. 165."},{"key":"10.1016\/j.jiph.2025.102940_bib15","first-page":"569","volume":"46","author":"Foster","year":"1972"},{"issue":"6","key":"10.1016\/j.jiph.2025.102940_bib16","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/oxfordjournals.aje.a114328","article-title":"Four generations of probable person-to-person transmission of human monkeypox","volume":"123","author":"Jezek","year":"1986","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.jiph.2025.102940_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","article-title":"Human monkeypox: clinical features of 282 patients","volume":"156","author":"Jezek","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib18","article-title":"VI: epidemiology of human monkeypox","author":"Karger","year":"2024","journal-title":"Monkeypox"},{"issue":"10","key":"10.1016\/j.jiph.2025.102940_bib19","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400189","article-title":"Tecovirimat use under expanded access to treat mpox in the United States, 2022\u20132023","volume":"3","author":"Yu","year":"2024","journal-title":"NEJM Evid"},{"issue":"37","key":"10.1016\/j.jiph.2025.102940_bib20","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.jiph.2025.102940_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.15585\/mmwr.mm6710a5","article-title":"Emergence of monkeypox - west and Central Africa, 1970-2017","volume":"67","author":"Durski","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib22","first-page":"31","article-title":"Serological survey for human monkeypox infections in a selected population in Zaire","volume":"90","author":"Jezek","year":"1987","journal-title":"J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.jiph.2025.102940_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ije\/17.3.643","article-title":"The transmission potential of monkeypox virus in human populations","volume":"17","author":"FINE","year":"1988","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jiph.2025.102940_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102402","article-title":"Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: emergence of a novel viral lineage?","volume":"49","author":"Luna","year":"2022","journal-title":"Travel Med Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2025.102940_bib25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2406.180017","article-title":"Reemergence of human monkeypox in Nigeria, 2017","volume":"24","author":"Yinka-Ogunleye","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib26","article-title":"Weekly bulletin on outbreaks and other emergencies","volume":"26","author":"W. H. Organization","year":"2018"},{"key":"10.1016\/j.jiph.2025.102940_bib27","series-title":"Monkeypox \u2013 Nigeria","author":"W. H. Organization","year":"2017"},{"issue":"3","key":"10.1016\/j.jiph.2025.102940_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.15585\/mmwr.mm7203a4","article-title":"Epidemiology of human mpox - worldwide, 2018-2021","volume":"72","author":"McCollum","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.jiph.2025.102940_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/v14061283","article-title":"Travel-Related monkeypox outbreaks in the era of COVID-19 pandemic: are we prepared?","volume":"14","author":"Adegboye","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.jiph.2025.102940_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.inf.0000101821.61387.a5","article-title":"A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values","volume":"22","author":"Anderson","year":"2003","journal-title":"Pedia Infect Dis J"},{"key":"10.1016\/j.jiph.2025.102940_bib31","article-title":"Pre- and asymptomatic viral shedding in high-risk contacts of monkeypox cases: a prospective cohort study","author":"Brosius","year":"2022","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib32","first-page":"459","article-title":"Clinico-epidemiological features of monkeypox patients with an animal or human source of infection","volume":"66","author":"Jezek","year":"1988","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jiph.2025.102940_bib33","first-page":"1022","volume":"159","author":"Kile","year":"2005","journal-title":"Transm Monkey Pers Expo infected Prairie dogs Indiana 2003"},{"key":"10.1016\/j.jiph.2025.102940_bib34","article-title":"Novel clade I genome sequences from the ongoing mpox virus outbreak of kamituga in south kivu province","author":"Masirika","year":"2024","journal-title":"Democr Repub Congo"},{"issue":"24","key":"10.1016\/j.jiph.2025.102940_bib35","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200448","article-title":"Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022","volume":"27","author":"Miura","year":"2022","journal-title":"Eur Surveill"},{"key":"10.1016\/j.jiph.2025.102940_bib36","unstructured":"W. H. Organization. \"Weekly Bulletin on Outbreaks and Other Emergencies, Week 42 2017.\" World Health Organization. \u3008http:\/\/apps.who.int\/iris\/bitstream\/10665\/259352\/1\/OEW42-1420102017.pdf\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib37","unstructured":"W. H. Organization. \"Multi-country outbreak of mpox, External situation report #40.\" World Health Organization. \u3008https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-mpox--external-situation-report-40--13-october-2024\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib38","unstructured":"W. H. Organization. \"Multi-country outbreak of mpox, External situation report #35.\" World Health Organization. \u3008https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-mpox--external-situation-report-35--12-august-2024\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib39","unstructured":"W. H. Organization. \"Mpox - Democratic Republic of the Congo.\" World Health Organization. \u3008https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2024-DON522\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib40","doi-asserted-by":"crossref","unstructured":"C. f. D. C. a. Prevention, \"Multistate Outbreak of Monkeypox\u2014 Illinois, Indiana, and Wisconsin, 2003,\" JAMA, vol. 290, no. 1, pp. 30-31, 2003, doi: 10.1001\/jama.290.1.30.","DOI":"10.1001\/jama.290.1.30"},{"key":"10.1016\/j.jiph.2025.102940_bib41","article-title":"Centers for disease control and prevention","author":"Prevention","year":"2024","journal-title":"Mpox U S World Curr Situat"},{"key":"10.1016\/j.jiph.2025.102940_bib42","first-page":"342","article-title":"Ed","volume":"350","author":"Reed","year":"2004"},{"key":"10.1016\/j.jiph.2025.102940_bib43","unstructured":"R. O. f. A. World Health Organization. \"Regional Office for Africa Node 20198.\" World Health Organization. \u3008https:\/\/www.afro.who.int\/pt\/node\/20198\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib44","series-title":"Mpox outbreak: global trends","first-page":"2022","author":"W. H. Organization","year":"2025"},{"key":"10.1016\/j.jiph.2025.102940_bib45","unstructured":"W. H. Organization, \"Multi-country outbreak of mpox, External situation report #54 - 27 June 2025,\" Geneva, 2025. Accessed: 10 July 2025. [Online]. Available: \u3008https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20250627_mpox-sitrep--54.pdf?sfvrsn=a53617e4_3&download=true\u3009."},{"issue":"8","key":"10.1016\/j.jiph.2025.102940_bib46","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jiph.2025.102940_bib47","unstructured":"C. f. D. C. a. Prevention. \"Clade I Mpox Outbreak Originating in Central Africa.\" Centers for Disease Control and Prevention. \u3008https:\/\/www.cdc.gov\/mpox\/outbreaks\/2023\/index.html#:\u223c:text=The%20Republic%20of%20the%20Congo,cases%20have%20links%20to%20DRC\u3009. (accessed 19 November 2024."},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib48","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12879-025-10896-5","article-title":"Recurrent mpox: divergent virulent clades and the urgent need for strategic measures including novel vaccine development to sustain global health security","volume":"25","author":"Ebede","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib49","unstructured":"W. H. Organization. \"World Health Organization best practices for the naming of new human infectious diseases.\" World Health Organization. \u3008https:\/\/www.who.int\/publications\/i\/item\/WHO-HSE-FOS-15.1\u3009 (accessed."},{"issue":"3","key":"10.1016\/j.jiph.2025.102940_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1473-3099(23)00055-5","article-title":"New nomenclature for mpox (monkeypox) and monkeypox virus clades","volume":"23","author":"Ulaeto","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib51","unstructured":"\"Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus - MPXV - Virological.\" \u3008https:\/\/virological.org\/t\/urgent-need-for-a-non-discriminatory-and-non-stigmatizing-nomenclature-for-monkeypox-virus\/853\u3009 (accessed."},{"issue":"11","key":"10.1016\/j.jiph.2025.102940_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/v12111257","article-title":"Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution","volume":"12","author":"Alakunle","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2025.102940_bib53","first-page":"1002","article-title":"Imported monkeypox from international traveler, maryland, USA, 2021","volume":"28","author":"Costello","year":"2022","journal-title":"ed Cent Dis Control Prev"},{"key":"10.1016\/j.jiph.2025.102940_bib54","first-page":"1367","article-title":"Exportation of monkeypox virus from the African continent","volume":"225","author":"Mauldin","year":"2022","journal-title":"ed"},{"key":"10.1016\/j.jiph.2025.102940_bib55","first-page":"509","article-title":"Monkeypox in a traveler returning from Nigeria \u2014 dallas, texas, July 2021","volume":"71","author":"Rao","year":"2022","journal-title":"ed Cent Dis Control Prev"},{"issue":"9","key":"10.1016\/j.jiph.2025.102940_bib56","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/molbev\/msq088","article-title":"Using time-structured data to estimate evolutionary rates of double-stranded DNA viruses","volume":"27","author":"Firth","year":"2010","journal-title":"Mol Biol Evol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28036","article-title":"Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022","volume":"95","author":"Wang","year":"2023","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.jiph.2025.102940_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00062-23","article-title":"An APOBEC3 mutational signature in the genomes of Human-Infecting orthopoxviruses","volume":"8","author":"Forni","year":"2023","journal-title":"mSphere"},{"issue":"6670","key":"10.1016\/j.jiph.2025.102940_bib59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.adg8116","article-title":"APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016","volume":"382","author":"O'Toole","year":"2023","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41392-022-01181-x","article-title":"The monkeypox outbreak in 2022: adaptive evolution associated with APOBEC3 May account for","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"10.1016\/j.jiph.2025.102940_bib61","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/infdis\/jiad165","article-title":"APOBEC3F is a mutational driver of the human monkeypox virus identified in the 2022 outbreak","volume":"228","author":"Susp\u00e8ne","year":"2023","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib62","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"Karagoz","year":"2023","journal-title":"J Infect Public Health"},{"issue":"10","key":"10.1016\/j.jiph.2025.102940_bib63","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.4049\/jimmunol.1501504","article-title":"APOBEC3 proteins in viral immunity","volume":"195","author":"Stavrou","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jiph.2025.102940_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/683095","article-title":"The role of cytidine deaminases on innate immune responses against human viral infections","volume":"2013","author":"Vieira","year":"2013","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.jiph.2025.102940_bib65","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010199","article-title":"Poxvirus DNA replication","volume":"5","author":"Moss","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jiph.2025.102940_bib66","doi-asserted-by":"crossref","first-page":"8845911","DOI":"10.1155\/ghe3\/8845911","article-title":"Genomic evolution and epidemiological impact of ongoing clade ib MPox disease: a narrative review","volume":"2025","author":"Akingbola","year":"2025","journal-title":"Glob Health Epidemiol Genom"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib67","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","article-title":"Virulence differences between monkeypox virus isolates from West Africa and the Congo basin","volume":"340","author":"Chen","year":"2005","journal-title":"Virology"},{"issue":"41","key":"10.1016\/j.jiph.2025.102940_bib68","doi-asserted-by":"crossref","first-page":"918","DOI":"10.46234\/ccdcw2023.173","article-title":"Genetic features of 84 genomes of monkeypox virus in recent circulation - Beijing municipality, China, 2023","volume":"5","author":"Zhang","year":"2023","journal-title":"China CDC Wkly"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib69","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3855\/jidc.20136","article-title":"Complete genome sequencing, annotation, and mutational profiling of the novel clade I human mpox virus, kamituga strain","volume":"18","author":"Masirika","year":"2024","journal-title":"J Infect Dev Ctries"},{"issue":"11","key":"10.1016\/j.jiph.2025.102940_bib70","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.11.2400106","article-title":"Ongoing mpox outbreak in kamituga, south kivu province, associated with monkeypox virus of a novel clade I sub-lineage, democratic republic of the Congo, 2024","volume":"29","author":"Masirika","year":"2024","journal-title":"Eur Surveill"},{"issue":"10498","key":"10.1016\/j.jiph.2025.102940_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(25)00294-6","article-title":"Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade ia lineage: a retrospective, observational study","volume":"406","author":"Wawina-Bokalanga","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2025.102940_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102855","article-title":"The 2022 outbreak and the pathobiology of the monkeypox virus","volume":"131","author":"Kumar","year":"2022","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.jiph.2025.102940_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030957","article-title":"Demographic, epidemiologic, and clinical characteristics of human monkeypox disease Pre- and Post-2022 outbreaks: a systematic review and Meta-Analysis","volume":"11","author":"Hatami","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib74","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1186\/s12879-022-07900-7","article-title":"Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease","volume":"22","author":"Sukhdeo","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib75","unstructured":"C. f. D. C. a. Prevention. \"Mpox in Animals and Pets.\" Centers for Disease Control and Prevention. \u3008https:\/\/www.cdc.gov\/mpox\/about\/mpox-in-animals-and-pets.html\u3009 (accessed."},{"issue":"67","key":"10.1016\/j.jiph.2025.102940_bib76","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.21105\/joss.03773","article-title":"Nextclade: clade assignment, mutation calling and quality control for viral genomes","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.jiph.2025.102940_bib77","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/sysbio\/syy032","article-title":"Posterior summarization in Bayesian phylogenetics using tracer 1.7","volume":"67","author":"Rambaut","year":"2018","journal-title":"Syst Biol"},{"key":"10.1016\/j.jiph.2025.102940_bib78","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s11262-023-02002-1","article-title":"Extensive ITR expansion of the 2022 mpox virus genome through gene duplication and gene loss","volume":"59","author":"Brinkmann","year":"2023","journal-title":"Virus Genes"},{"key":"10.1016\/j.jiph.2025.102940_bib79","unstructured":"W. H. Organization. \"Mpox.\" \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mpox\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib80","unstructured":"W. H. Organization. \"WHO-MPX-Clinical-and-IPC-2022.1.\" \u3008https:\/\/www.who.int\/publications\/i\/item\/WHO-MPX-Clinical-and-IPC-2022.1\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.56","article-title":"Ggtree: a serialized data object for visualization of a phylogenetic tree and annotation data","volume":"1","author":"Xu","year":"2022","journal-title":"iMeta"},{"key":"10.1016\/j.jiph.2025.102940_bib82","article-title":"\"Global genomic surveillance of monkeypox virus","volume":"2024","author":"Otieno","year":"2024","journal-title":"Nat Med"},{"issue":"10370","key":"10.1016\/j.jiph.2025.102940_bib83","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(22)02075-X","article-title":"Monkeypox","volume":"401","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2025.102940_bib84","unstructured":"C. f D.C. a Prevention. \"How Mpox Spreads.\" https:\/\/www.cdc.gov\/mpox\/causes\/index.html (accessed 5 November 2024."},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12010146","article-title":"Clinical characteristics of human mpox (Monkeypox) in 2022: a systematic review and Meta-Analysis","volume":"12","author":"Liu","year":"2023","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.jiph.2025.102940_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28230","article-title":"A systematic review and clinical Atlas on mucocutaneous presentations of the current monkeypox outbreak: with a comprehensive approach to all dermatologic and nondermatologic aspects of the new and previous monkeypox outbreaks","volume":"95","author":"Pourriyahi","year":"2023","journal-title":"J Med Virol"},{"issue":"19","key":"10.1016\/j.jiph.2025.102940_bib87","doi-asserted-by":"crossref","first-page":"435","DOI":"10.15585\/mmwr.mm7319a3","article-title":"U.S. Preparedness and response to increasing clade I mpox cases in the democratic republic of the Congo - United States, 2024","volume":"73","author":"McQuiston","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib88","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/S2666-5247(23)00034-4","article-title":"Mpox respiratory transmission: the state of the evidence","volume":"4","author":"Beeson","year":"2023","journal-title":"Lancet Microbe"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib89","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3201\/eid2604.191164","article-title":"Human-to-Human transmission of monkeypox virus, United Kingdom, October 2018","volume":"26","author":"Vaughan","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.jiph.2025.102940_bib90","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.3201\/eid2810.221047","article-title":"Environmental persistence of monkeypox virus on surfaces in household of person with Travel-Associated infection, dallas, texas, USA, 2021","volume":"28","author":"Morgan","year":"2022","journal-title":"Emerg Infect Dis J"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib91","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3201\/eid2904.221921","article-title":"Mpox in young woman with no epidemiologic risk factors, massachusetts, USA","volume":"29","author":"Siedner","year":"2023","journal-title":"Emerg Infect Dis J"},{"issue":"26","key":"10.1016\/j.jiph.2025.102940_bib92","article-title":"Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022","volume":"27","author":"N\u00f6rz","year":"2022","journal-title":"Eng) Eur Surveill"},{"issue":"10","key":"10.1016\/j.jiph.2025.102940_bib93","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1111\/1462-2920.16129","article-title":"Infection-competent monkeypox virus contamination identified in domestic settings following an imported case of monkeypox into the UK","volume":"24","author":"Atkinson","year":"2022","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.jiph.2025.102940_bib94","unstructured":"N. England. \"Infection prevention and control measures for clinically suspected and confirmed cases of mpox in healthcare settings.\" \u3008https:\/\/www.england.nhs.uk\/long-read\/infection-prevention-and-control-measures-for-clinically-suspected-and-confirmed-cases-of-mpox-in-healthcare-settings\/\u3009 (accessed."},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/v17040456","article-title":"Vaccines and antiviral therapies for mpox virus in pregnant and breastfeeding women: efficacy and Maternal-Child outcomes","volume":"17","author":"Imran","year":"2025","journal-title":"Viruses"},{"issue":"14","key":"10.1016\/j.jiph.2025.102940_bib96","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJMp2410045","article-title":"Mpox in pregnancy \u2014 risks, vertical transmission, prevention, and treatment","volume":"391","author":"Nachega","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib97","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1016\/S2214-109X(23)00607-1","article-title":"Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis","volume":"12","author":"Sanchez Clemente","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"19","key":"10.1016\/j.jiph.2025.102940_bib98","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMra2208860","article-title":"Monkeypox","volume":"387","author":"Gessain","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib99","doi-asserted-by":"crossref","first-page":"D54","DOI":"10.1016\/j.vaccine.2011.04.014","article-title":"Status of human monkeypox: clinical disease, epidemiology and research","volume":"29","author":"Damon","year":"2011","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.jiph.2025.102940_bib100","doi-asserted-by":"crossref","first-page":"764","DOI":"10.15585\/mmwr.mm7123e1","article-title":"Monkeypox outbreak - nine states, May 2022","volume":"71","author":"Minhaj","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10353","key":"10.1016\/j.jiph.2025.102940_bib101","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study","volume":"400","author":"Tar\u00edn-Vicente","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2025.102940_bib102","unstructured":"C. f. D. C. a. Prevention. \"Clinical Features of Mpox.\" \u3008https:\/\/www.cdc.gov\/mpox\/hcp\/clinical-signs\/index.html\u3009 (accessed 2024."},{"issue":"12","key":"10.1016\/j.jiph.2025.102940_bib103","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1086\/498115","article-title":"Clinical characteristics of human monkeypox, and risk factors for severe disease","volume":"41","author":"Huhn","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2025.102940_bib104","first-page":"370","article-title":"Monkeypox: another pandemic in the making?","volume":"36","author":"Sohal","year":"2023","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"8","key":"10.1016\/j.jiph.2025.102940_bib105","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2025.102940_bib106","article-title":"Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series","volume":"378","author":"Patel","year":"2022","journal-title":"Bmj"},{"issue":"12","key":"10.1016\/j.jiph.2025.102940_bib107","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/ijd.17477","article-title":"Mpox challenges in a clinical setting: patterns of skin lesions, diagnostic clues, and long-term consequences","volume":"63","author":"Tanasov","year":"2024","journal-title":"Int J Dermatol"},{"issue":"19","key":"10.1016\/j.jiph.2025.102940_bib108","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2024.21091","article-title":"Mpox clinical presentation, diagnostic approaches, and treatment strategies: a review","volume":"332","author":"Titanji","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jiph.2025.102940_bib109","unstructured":"W. H. Organization, Atlas of mpox lesions: a tool for clinical researchers, version 1.0, 28 April 2023. France: World Health Organization, 2023."},{"issue":"12","key":"10.1016\/j.jiph.2025.102940_bib110","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.ajt.2023.07.016","article-title":"Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: a multicenter case series and literature review","volume":"23","author":"Higgins","year":"2023","journal-title":"Am J Transpl"},{"issue":"6","key":"10.1016\/j.jiph.2025.102940_bib111","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11904-023-00682-w","article-title":"Mpox and HIV-Collision of two diseases","volume":"20","author":"Zucker","year":"2023","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"10.1016\/j.jiph.2025.102940_bib112","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ajog.2022.08.017","article-title":"Monkeypox in pregnancy: virology, clinical presentation, and obstetric management","volume":"227","author":"Dashraath","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.jiph.2025.102940_bib113","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/ijd.17500","article-title":"Prospective observational study on scar sequelae after MPOX infection: an analysis of 40 patients","volume":"63","author":"Grau-Echevarr\u00eda","year":"2024","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib114","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12879-025-10899-2","article-title":"Advancing the understanding and management of mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies","volume":"25","author":"Hajjo","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000528041","article-title":"Monkeypox-Associated acute kidney injury and foreseeable impacts on nephrology and kidney transplantation services","volume":"52","author":"Reis","year":"2023","journal-title":"Blood Purif"},{"issue":"12","key":"10.1016\/j.jiph.2025.102940_bib116","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/ijd.17502","article-title":"Dermoscopic insights into genital monkeypox: unveiling the \"Chinese doughnuts\" sign","volume":"63","author":"Gao","year":"2024","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jiph.2025.102940_bib117","unstructured":"C. f. D. C. a. Prevention. \"Mpox diagnosis and testing.\" CDC. \u3008https:\/\/www.cdc.gov\/mpox\/hcp\/diagnosis-testing\/index.html\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib118","unstructured":"W. H. Organization. \"WHO approves first Mpox diagnostic test for emergency use, boosting global access.\" \u3008https:\/\/www.who.int\/news\/item\/03-10-2024-who-approves-first-mpox-diagnostic-test-for-emergency-use--boosting-global-access\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib119","unstructured":"W. H. Organization. \"WHO lists additional Mpox diagnostic tests for emergency use.\" \u3008https:\/\/www.who.int\/news\/item\/30-10-2024-who-lists-additional-mpox-diagnostic-tests-for-emergency-use\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib120","unstructured":"A. C. f. D. C. a. Prevention. \"Morocco\u2019s first homegrown PCR test for mpox gets Africa CDC nod.\" Africa CDC. \u3008https:\/\/africacdc.org\/news-item\/moroccos-first-homegrown-pcr-test-for-mpox-gets-africa-cdc-nod\/\u3009 (accessed."},{"issue":"11","key":"10.1016\/j.jiph.2025.102940_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/s41415-022-4357-9","article-title":"Deep masseteric layer","volume":"232","author":"Tufail","year":"2022","journal-title":"Br Dent J"},{"key":"10.1016\/j.jiph.2025.102940_bib122","first-page":"1027","article-title":"Human monkeypox: epidemiologic and clinical characteristics","volume":"33","author":"Petersen","year":"2019","journal-title":"Diagn Prev"},{"issue":"10","key":"10.1016\/j.jiph.2025.102940_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001356","article-title":"Assessing the effectiveness of a community intervention for monkeypox prevention in the Congo basin","volume":"5","author":"Roess","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"22","key":"10.1016\/j.jiph.2025.102940_bib124","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the advisory committee on immunization Practices\u2014United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"Morbidity Mortality Weekly Rep"},{"key":"10.1016\/j.jiph.2025.102940_bib125","first-page":"192","article-title":"Protection of rhesus monkeys against monkeypox by vaccinia virus immunization","volume":"25","author":"McConnell","year":"1964","journal-title":"Am J Vet Res"},{"issue":"8","key":"10.1016\/j.jiph.2025.102940_bib126","first-page":"1675","article-title":"Monkeypox: experimental infection in chimpanzee (Pan satyrus) and immunization with vaccinia virus","volume":"29","author":"McConnell","year":"1968","journal-title":"Am J Vet Res"},{"issue":"2","key":"10.1016\/j.jiph.2025.102940_bib127","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF01241445","article-title":"Histo-palhological and virological studies on monkey-pox","volume":"21","author":"Gispen","year":"1967","journal-title":"Arch fur die Gesamt Virusforsch"},{"issue":"6979","key":"10.1016\/j.jiph.2025.102940_bib128","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jiph.2025.102940_bib129","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine\u2013induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.vaccine.2007.10.063","article-title":"Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge","volume":"26","author":"Marriott","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jiph.2025.102940_bib131","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.jiph.2025.102940_bib132","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1128\/JVI.03481-12","article-title":"Assessment of the protective effect of imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques","volume":"87","author":"Hatch","year":"2013","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.jiph.2025.102940_bib133","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1128\/JVI.02642-05","article-title":"LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox","volume":"80","author":"Saijo","year":"2006","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.jiph.2025.102940_bib134","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/infdis\/jiq162","article-title":"Smallpox vaccine safety is dependent on t cells and not b cells","volume":"203","author":"Gordon","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.102940_bib135","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7883\/yoken.JJID.2016.417","article-title":"A single vaccination of nonhuman primates with highly attenuated smallpox vaccine, LC16m8, provides long-term protection against monkeypox","volume":"70","author":"Iizuka","year":"2017","journal-title":"Jpn J Infect Dis"},{"issue":"9","key":"10.1016\/j.jiph.2025.102940_bib136","article-title":"The emergence of monkeypox: a global health threat","volume":"14","author":"Sah","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jiph.2025.102940_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00574-6","article-title":"Prevention of monkeypox with vaccines: a rapid review","author":"Poland","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib138","unstructured":"C. f D.C. a. Prevention. \u3008https:\/\/www.cdc.gov\/smallpox\/clinicians\/vaccines.html#:\u223c:text=The%20FDA%20has%20licensed%20JYNNEOS,prevention%20of%20smallpox%20and%20monkeypox\u3009. (accessed 29 October 2024."},{"key":"10.1016\/j.jiph.2025.102940_bib139","unstructured":"F. a D. Administration. \"FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox.\" \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-live-non-replicating-vaccine-prevent-smallpox-and-monkeypox\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib140","unstructured":"C. f. D. C. a. Prevention. \"Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022.\" \u3008https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7122e1.htm\u3009 (accessed 29 October 2024."},{"key":"10.1016\/j.jiph.2025.102940_bib141","unstructured":"E.M. Agency. \"EMA\u2019s Emergency Task Force advises on intradermal use of Imvanex \/ Jynneos against monkeypox \" \u3008https:\/\/www.ema.europa.eu\/en\/news\/emas-emergency-task-force-advises-intradermal-use-imvanex-jynneos-against-monkeypox\u3009 (accessed 2024."},{"key":"10.1016\/j.jiph.2025.102940_bib142","unstructured":"C. f D.C. a Prevention. \"Mpox Vaccination.\" Centers for Disease Control and Prevention. \u3008https:\/\/www.cdc.gov\/mpox\/vaccines\/index.html\u3009 (accessed 2024."},{"key":"10.1016\/j.jiph.2025.102940_bib143","unstructured":"C. f D.C. a Prevention. \"Vaccine for Mpox Prevention in the United States.\" \u3008https:\/\/www.cdc.gov\/mpox\/hcp\/vaccine-considerations\/index.html#:\u223c:text=ACAM2000%20vaccine%20is%20approved%20for,known%20side%20effects%20and%20contraindications\u3009. (accessed 20 September 2024."},{"key":"10.1016\/j.jiph.2025.102940_bib144","unstructured":"E.M. Agency. \"EMA recommends extending indication of mpox vaccine to adolescents.\" \u3008https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-extending-indication-mpox-vaccine-adolescents\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib145","unstructured":"W. H. Organization. \"WHO grants approval for use of Bavarian Nordic\u2019s mpox vaccine in adolescents.\" \u3008https:\/\/extranet.who.int\/prequal\/news\/who-grants-approval-use-bavarian-nordics-mpox-vaccine-adolescents\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib146","unstructured":"N.I. o Health. \"Mpox vaccine is safe and generates a robust antibody response in adolescents.\" \u3008https:\/\/www.nih.gov\/news-events\/news-releases\/mpox-vaccine-safe-generates-robust-antibody-response-adolescents\u3009 (accessed 25 October 2024."},{"key":"10.1016\/j.jiph.2025.102940_bib147","unstructured":"C. f D.C. a Prevention. \"Interim Clinical Considerations for Use of Vaccine for Mpox Prevention in the United States.\" \u3008https:\/\/www.cdc.gov\/mpox\/hcp\/vaccine-considerations\/vaccination-overview.html\u3009 (accessed 20 September 2024."},{"key":"10.1016\/j.jiph.2025.102940_bib148","unstructured":"F. a. D. Administration. \"ACAM2000 (Smallpox Vaccine) Questions and Answers.\" \u3008https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/acam2000-smallpox-vaccine-questions-and-answers#:\u223c:text=ACAM2000%2C%20a%20%22s%20generation%22,using%20modern%20cell%20culture%20technology\u3009. (accessed 21 October 2024."},{"key":"10.1016\/j.jiph.2025.102940_bib149","unstructured":"W. H. Organization. \"WHO adds LC16m8 Mpox vaccine to emergency use listing.\" WHO. \u3008https:\/\/www.who.int\/news\/item\/19-11-2024-who-adds-lc16m8-mpox-vaccine-to-emergency-use-listing\u3009 (accessed."},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.imj.2025.100166","article-title":"Personalized immunization against mpox clades I and ib: strategies to combat the emerging epidemic","volume":"4","author":"Kumar","year":"2025","journal-title":"Infect Med"},{"key":"10.1016\/j.jiph.2025.102940_bib151","unstructured":"I. Moderna. \"A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From \u226518 Years of Age to <50 Years of Age.\" \u3008https:\/\/trials.modernatx.com\/study\/?id=mRNA-1769-P101\u3009 (accessed."},{"issue":"20","key":"10.1016\/j.jiph.2025.102940_bib152","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","article-title":"Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates","volume":"187","author":"Mucker","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jiph.2025.102940_bib153","unstructured":"B. SE. \"A Clinical Study Investigating the Safety and Immune Responses After Immunization with Investigational Monkeypox Vaccines.\" \u3008https:\/\/clinicaltrials.biontech.com\/trials\/BNT166-01\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib154","unstructured":"B. Nordic. \"First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic\u2019s Mpox Vaccine.\" \u3008https:\/\/www.bavarian-nordic.com\/media\/media\/news.aspx?news=7015\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib155","unstructured":"ClinicalTrials.gov. \"Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections.\" \u3008https:\/\/clinicaltrials.gov\/study\/NCT06549530\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib156","unstructured":"Monkeypox.\" World Health Organization (WHO). \u3008https:\/\/www.who.int\/health-topics\/monkeypox\/#tab=tab_3\u3009 (accessed."},{"key":"10.1016\/j.jiph.2025.102940_bib157","series-title":"Mpox (Monkeypox) [Updated 2022 Nov 30]","article-title":"StatPearls [Internet]. treasure island (FL)","author":"Moore","year":"2022"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib158","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/tropicalmed1010008","article-title":"Human monkeypox: current state of knowledge and implications for the future","volume":"1","author":"Brown","year":"2016","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib159","unstructured":"C. f D.C. a Prevention. \"Clinical Treatment of Mpox.\" \u3008https:\/\/www.cdc.gov\/mpox\/hcp\/clinical-care\/index.html#:\u223c:text=Expanded%20Access%2DInvestigational%20New%20Drug%20\u3009(IND)%20Protocol,and%20pregnant%20or%20breastfeeding%20adults. (accessed 20 September 2024."},{"issue":"15","key":"10.1016\/j.jiph.2025.102940_bib160","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJMoa2412439","article-title":"Tecovirimat for clade I MPXV infection in the democratic Republic of Congo","volume":"392","author":"Ali","year":"2025","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jiph.2025.102940_bib161","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/v14091870","article-title":"A glance at the development and patent literature of tecovirimat: the first-in-class therapy for emerging monkeypox outbreak","volume":"14","author":"Almehmadi","year":"2022","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.jiph.2025.102940_bib162","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","article-title":"Prevention and treatment of monkeypox","volume":"82","author":"Rizk","year":"2022","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.jiph.2025.102940_bib163","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/jac\/dky192","article-title":"Model of population pharmacokinetics of cidofovir in immunocompromised children with cytomegalovirus and adenovirus infection","volume":"73","author":"Neant","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib164","article-title":"Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model","volume":"6","author":"Hutson","year":"2021","journal-title":"MSphere"},{"key":"10.1016\/j.jiph.2025.102940_bib165","article-title":"Monkeypox (hMPXV infection): a practical review","author":"Salcedo","year":"2022","journal-title":"Am J Med"},{"issue":"40","key":"10.1016\/j.jiph.2025.102940_bib166","doi-asserted-by":"crossref","first-page":"903","DOI":"10.15585\/mmwr.mm7340a3","article-title":"Mpox cluster caused by Tecovirimat-Resistant monkeypox virus \u2014 five states, October 2023\u2013February 2024","volume":"73","author":"T. J. Gigante","year":"2024","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiph.2025.102940_bib167","first-page":"1","article-title":"Challenges in managing Treatment-Resistant mpox complicated by severe superinfection","volume":"2024","author":"M. C. Fortier","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.102940_bib168","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cid\/ciac622","article-title":"Antivirals with activity against mpox: a clinically oriented review","volume":"76","author":"Siegrist","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jiph.2025.102940_bib169","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib170","article-title":"Tecovirimat for the treatment of human monkeypox: an initial series from massachusetts, United States","volume":"9","author":"Matias","year":"2022"},{"key":"10.1016\/j.jiph.2025.102940_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2022.e01587","article-title":"Monkeypox\u2013an emerging pandemic","volume":"29","author":"Ajmera","year":"2022","journal-title":"IDCases"},{"issue":"13","key":"10.1016\/j.jiph.2025.102940_bib172","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jama.2022.15336","article-title":"Compassionate use of tecovirimat for the treatment of monkeypox infection","volume":"328","author":"Desai","year":"2022","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.jiph.2025.102940_bib173","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.7326\/L22-0300","article-title":"Monkeypox virus\u2013associated severe proctitis treated with oral tecovirimat: a report of two cases","volume":"175","author":"Lucar","year":"2022","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.jiph.2025.102940_bib174","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.joms.2022.07.147","article-title":"Oral manifestations of monkeypox: a report of 2 cases","volume":"80","author":"Peters","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.jiph.2025.102940_bib175","article-title":"Inpatient management of monkeypox","volume":"1","author":"Shaw","year":"2022","journal-title":"Brown Hosp Med"},{"issue":"08","key":"10.1016\/j.jiph.2025.102940_bib176","article-title":"Monkeypox treatment with tecovirimat in the Central African Republic under an expanded access programme","volume":"2022","author":"Mbrenga","year":"2022","journal-title":"MedRxiv"},{"issue":"10355","key":"10.1016\/j.jiph.2025.102940_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(22)01528-8","article-title":"Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat","volume":"400","author":"Hernandez","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2025.102940_bib178","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7142e1","article-title":"Ocular Monkeypox\u2014United States, July\u2013September 2022","volume":"71","author":"S. Cash-Goldwasser","year":"2022","journal-title":"Mmwr Morb Mortal Wkly Rep"},{"issue":"38","key":"10.1016\/j.jiph.2025.102940_bib179","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.15585\/mmwr.mm7138e1","article-title":"Two cases of monkeypox-associated encephalomyelitis\u2014Colorado and the district of Columbia, July\u2013August 2022","volume":"71","author":"Pastula","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jiph.2025.102940_bib180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijid.2022.10.031","article-title":"A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome","volume":"125","author":"Viguier","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib181","article-title":"Tecovirimat therapy for severe monkeypox infection: longitudinal assessment of viral titers and clinical response pattern\u2014a first case-series experience","author":"Hermanussen","year":"2022","journal-title":"J Med Virol"},{"issue":"9","key":"10.1016\/j.jiph.2025.102940_bib182","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1473-3099(22)00411-X","article-title":"Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis","volume":"22","author":"Girometti","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102417","article-title":"Hospitalisation for monkeypox in milan, Italy","volume":"49","author":"Moschese","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.jiph.2025.102940_bib184","article-title":"Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study","author":"Mailhe","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiph.2025.102940_bib185","article-title":"Real-life use of cidofovir for the treatment of severe monkeypox cases","author":"Raccagni","year":"2022","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.jiph.2025.102940_bib186","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.ophtha.2022.08.013","article-title":"Unilateral blepharoconjunctivitis due to monkeypox virus infection","volume":"129","author":"Scandale","year":"2022","journal-title":"Ophthalmology"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125002898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125002898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:57:17Z","timestamp":1756933037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125002898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":186,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1876034125002898"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102940","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mpox infection: A state-of-the-art overview of epidemiological, molecular, and clinical aspects following the 2024 public health emergency","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102940"}}